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André L. S. Santos1,2*
1 Department of General Microbiology, Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro,
Rio de Janeiro, Brazil, 2 Postgraduate Program in Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro,
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Elastase B (lasB) is a multifunctional metalloenzyme secreted by the gram-
negative pathogen Pseudomonas aeruginosa, and this enzyme orchestrates several
physiopathological events during bacteria-host interplays. LasB is considered to be
a potential target for the development of an innovative chemotherapeutic approach,
especially against multidrug-resistant strains. Recently, our group showed that
1,10-phenanthroline-5,6-dione (phendione), [Ag(phendione)2]ClO4 (Ag-phendione) and
[Cu(phendione)3](ClO4)2.4H2O (Cu-phendione) had anti-P. aeruginosa action against
both planktonic- and biofilm-growing cells. In the present work, we have evaluated
the effects of these compounds on the (i) interaction with the lasB active site using
in silico approaches, (ii) lasB proteolytic activity by using a specific fluorogenic peptide
substrate, (iii) lasB gene expression by real time-polymerase chain reaction, (iv) lasB
protein secretion by immunoblotting, (v) ability to block the damages induced by lasB
on a monolayer of lung epithelial cells, and (vi) survivability of Galleria mellonella larvae
after being challenged with purified lasB and lasB-rich bacterial secretions. Molecular
docking analyses revealed that phendione and its Ag+ and Cu2+ complexes were able
to interact with the amino acids forming the active site of lasB, particularly Cu-phendione
which exhibited the most favorable interaction energy parameters. Additionally, the test
compounds were effective inhibitors of lasB activity, blocking the in vitro cleavage
of the peptide substrate, aminobenzyl-Ala-Gly-Leu-Ala-p-nitrobenzylamide, with Cu-
phendione having the best inhibitory action (Ki = 90 nM). Treating living bacteria with
a sub-inhibitory concentration (1/2 × MIC value) of the test compounds caused a
significant reduction in the expression of the lasB gene as well as its mature protein
production/secretion. Further, Ag-phendione and Cu-phendione offered protective
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action for lung epithelial cells, reducing the A549 monolayer damage by approximately
32 and 42%, respectively. Interestingly, Cu-phendione mitigated the toxic effect of both
purified lasB molecules and lasB-containing bacterial secretions in the in vivo model,
increasing the survival time of G. mellonella larvae. Collectively, these data reinforce the
concept of lasB being a veritable therapeutic target and phendione-based compounds
(mainly Cu-phendione) being prospective anti-virulence drugs against P. aeruginosa.
Keywords: Pseudomonas aeruginosa, elastase B, metal-based compounds, 1,10-phenanthroline-5,6-dione, anti-
virulence therapy, theoretical calculations
INTRODUCTION
The effectiveness of antimicrobial therapy to treat bacterial
infectious diseases has been compromised by the emergence
of multidrug-resistant (MDR) strains (Brown and Wright,
2016). The failure of classical antibiotic approaches represents
a growing threat to public health worldwide. It has been
estimated that approximately 50,000 deaths per year within
the United States and Europe are due to antibiotic-resistant
microbial infections (Ali et al., 2018). Additionally, the infections
caused by antibiotic, non-responsive pathogens have prompted
the substantial rise in healthcare expenditures (Ventola, 2015).
According to the World Health Organization (Tacconelli et al.,
2018), the cost for the treatment of MDR infections in the
European Union exceeds 1.5 billion annually. In this respect, the
treatment of Pseudomonas aeruginosa infections is particularly
challenging due to the increasing global prevalence of MDR
strains (Sonmezer et al., 2016). This gram-negative bacterium
is armed with a sophisticated genetic machinery, presenting
a plasticity arsenal of antimicrobial resistance mechanisms
(Murray et al., 2015; Ali et al., 2018). Also, P. aeruginosa can
quickly develop resistance to antimicrobial drugs through the
acquisition of resistance genes in mobile genetic elements (Ali
et al., 2018). According to the surveillance study conducted
by the International Nosocomial Infection Control Consortium
(INICC), which analyzes the antimicrobial susceptibility profile
of strains recovered from patients admitted at intensive care units
in Latin America, Europe, Eastern Mediterranean, Southeast Asia
and Western Pacific countries, 29.9 and 44.3% of blood-cultured
P. aeruginosa strains were resistant to amikacin and imipenem,
respectively (Rosenthal et al., 2016).
Pseudomonas aeruginosa has a large range of extracellular
virulence attributes (e.g., proteases, pyocyanin, exotoxins, and
lipases), which are responsible for increasing its pathogenicity
(Balasubramanian et al., 2013). Collectively, the pseudomonal
virulence attributes enable the bacterium to (i) overcome
host immune defenses, (ii) cause host damages, and (iii)
induce dysfunctional alterations on the bacterial physiology
that favors the establishment and maintenance of an infectious
process (Azam and Khan, 2018). In this context, proteases
are the protagonists of numerous physiopathological events in
P. aeruginosa. Corroborating this statement, 3% of the open read
frames in the whole P. aeruginosa genome are responsible for
encoding proteases, which gives the bacterium the ability to adapt
its sophisticated enzymatic machinery according to both the
environment and to challenging conditions (Stover et al., 2000).
Multifunctional elastase B (lasB or pseudolysin) is the most
abundant protease harvested from pseudomonal secretome, and
it has been extensively studied (Galdino et al., 2017). LasB is
a neutral, metallo-type (Zn2+/Ca2+ cofactors) protease, whose
synthesis is guided by the expression of the lasB gene and is
regulated by the quorum sensing (QS) transcription systems, las
and rhl (Han et al., 2014). LasB is the protagonist molecule
in the acute stage of P. aeruginosa infections as it degrades
the extracellular matrix constituents (e.g., elastin, collagen types
III and IV, laminin, fibronectin, and vitronectin) of host cells,
inducing tissue injury and hemorrhage (Yang et al., 2015). Also,
lasB displays relevant actions during chronic infections through
its ability to manipulate host responses (Suarez-Cuartin et al.,
2017) by degrading several components of the immune defenses
(e.g., tumor necrosis factor-α, interferon-γ and interleukin-2)
and by inactivating cell-bound C1 and C3 and fluid-phase
C5, C8 and C9 components of the complement system (Kida
et al., 2008; Kuang et al., 2011). Corroborating the relevance
of lasB in the pathogenesis of P. aeruginosa, it was shown that
rabbits infected with a 1lasB mutant strain exhibited reduced
severity of corneal ulceration (Cowell et al., 2003). Likewise,
the deletion of the lasB gene resulted in a less invasive in vivo
infection in both mouse and Caenorhabditis elegans models when
compared to the infection caused by the respective wild-type
strain (Tang et al., 1996; Tan et al., 1999).
To overcome the rising threat of MDR P. aeruginosa,
the development of innovative chemotherapy is of immediate
necessity (Tacconelli et al., 2018). Consequently, some chemists
have focused their attention on the design and synthesis
of potential metal-based drug molecules (McCann et al.,
2012a). Metal-based antibiotics hold great promise due to
their reactivity with bacterial cells, presenting multi-target
and versatile mechanisms of action (Lemire et al., 2013).
Our interdisciplinary research team has synthetized novel
antimicrobial drug candidates based on 1,10-phenanthroline-5,6-
dione (phendione) coordinated to transition metals (McCann
et al., 2004). For instance, Ag+- and Cu2+-phendione complexes
presented potent anti-P. aeruginosa action, inhibiting both
planktonic- and biofilm-growing cells (Viganor et al., 2016).
Faced with the upcoming post-antibiotic era, the anti-
virulence approach emerges as a promising strategy against
superbug infections as it acts by disarming the virulence arsenal
of the pathogen and, consequently, reducing the ability of
the organism to damage host cells (Allen et al., 2014; Dickey
et al., 2017). Therefore, this therapeutic strategy reduces the
selective pressure on bacterial cells as well as delaying the
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emergence of non-responsive strains, since it does not affect
the bacterial proliferation mechanisms (Allen et al., 2014).
Hence, in view of the pivotal role of lasB in P. aeruginosa
pathogenesis, the inactivation of this multifunctional enzyme
is seemingly a promising target in anti-P. aeruginosa drug
design. In this sense, phendione is chemically derived from
1,10-phenanthroline, which is a potent inhibitor of metallo-
type proteases, including P. aeruginosa lasB (Galdino et al.,
2017). Herein, we have evaluated the effects of phendione and
its Cu2+ and Ag+ complexes on the (i) interaction with the
amino acids forming the lasB active site, (ii) lasB proteolytic
activity, (iii) lasB gene expression, (iv) lasB protein secretion,
(v) ability to block the damages induced by lasB on a lung
epithelial cell line, and (vi) survival of Galleria mellonella larvae
challenged with purified lasB molecules and lasB-containing
bacterial secretions.
MATERIALS AND METHODS
Compounds
1,10-Phenanthroline-5,6-dione (phendione), [Ag(phendione)2]
ClO4 (Ag-phendione) and [Cu(phendione)3](ClO4)2.4H2O (Cu-
phendione) (Figure 1) were synthetized in accordance to the
methods previously described in the literature (McCann et al.,
2004). The compounds were dissolved in dimethylsulfoxide
(DMSO) at 100 mM, then the solutions were sterilized by
filtration through a 0.22 µm membrane and stored at room
temperature in the dark.
In silico Analyses
Docking Procedure
In this theoretical analysis, docking calculations were employed
in order to (i) identify favorable structural features of phendione,
Ag-phendione and Cu-phendione through calculation of
interaction energies with the known P. aeruginosa lasB
inhibitor ligand, N-(1-carboxy-3-phenylpropyl)-phenylalanyl-
α-asparagine (HPI) [employing Molegro Virtual Docker software
(MVD R©)], and (ii) calculate their hydrogen bonding interaction
energies with amino acid residues within the cavity of the lasB
enzyme (employing Semi-empiric-PM6 calculation).
The chemical structure of each phendione-based test
compound was constructed and optimized at the semi-empirical
level by employing the PC Spartan Pro program (Hehre et al.,
1999). The partial charges on the atoms were also elucidated.
The phendione-based test compounds were then docked inside
the P. aeruginosa lasB crystallographic structure containing the
HPI inhibitor (PDB code: 1U4G; resolution: 1.4 Å) (Thayer et al.,
1991) by using the Molegro Virtual Docker software (MVD R©)
(Thomsen and Christensen, 2006), taking into account the same
procedures employed in previous works (Silva et al., 2015; Soares
et al., 2018). For the development of the docking calculations, a
radius of 5 Å centered at the active cavity was considered, where
the residues were kept flexible. Due to the nature of the employed
docking methods, the calculations were carried out generating 50
poses (conformation and orientation) for each phendione-based
test compound.
The MolDock scoring function employed in the MVD
program comes from the piecewise linear potential (PLP), a
simplified potential whose parameters are fitted to protein-ligand
structures, binding data scoring functions and further extended
in the Generic Evolutionary Method for molecular docking with a
new hydrogen binding term and new charge schemes (Goncalves
et al., 2014). Next, Equation (1) defines the docking scoring
function values (Escore):
Escore=Einter+ Eintra (1)
Wherein:
Einter =
∑
isligand
∑
jsprotein
[
EPLP(rij)+ 332.0 qiqj4r2ij
]
(2)
EPLP (piecewise linear potential) consists of two different
parameter sets: one for the approximation of the steric term (van
der Waals) among the atoms, and the other potential for the
hydrogen binding. The second term is related to the electrostatic
interactions among overloaded atoms. It is a Coulomb potential
with a dielectric constant dependent on the distance (D(r) = 4r).
The numerical value of 332.0 is assigned for the electrostatic
energy (in kcal mol−1) (Thomsen and Christensen, 2006). Eintra
is the internal energy of the ligand (Equation 3):
Eintra =
∑
isligand
∑
jsligand
EPLP(rij)+
∑
flexibonds
A[1− cos(m.θ− θ0)] + Eclash (3)
The first part of the equation (double summation) is among all
pairs of atoms in the ligand, taking off those that are connected
by two bonds. The second one characterizes the torsional energy,
wherein θ is the torsional angle of the bond. If several torsions
could be determined, each torsional energy is considered and
the average value used. The last term, Eclash, assigns a penalty of
1,000 if the distance between two heavy atoms (more than two
bonds apart) is smaller than 2.0 Å, disregarding infeasible ligand
conformations (Thomsen and Christensen, 2006). The docking
search algorithm that is applied in the MVD program algorithm
considers interactive optimization techniques that are inspired by
considering an evolutionary Darwinian theory and a new hybrid
search algorithm called guided differential evolution. This hybrid
combines the differential evolution optimization technique with
a cavity prediction algorithm during the search process, thus
permitting a fast and accurate identification of potential binding
modes (poses) (Thomsen and Christensen, 2006).
Semi-Empirical Methods
In this stage, a further theoretical investigation was carried
out in order to evaluate the electronic effects in obtaining the
interaction energy of the phendione-based test compounds. The
semi-empirical calculations were based on methods developed
by Michael Polanyi and Henry Eyring in 1931 (Morgon and
Coutinho, 2007), for coupling quantum theory to empirical
data. This category of semi-empirical methods makes it possible
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FIGURE 1 | Chemical structures of 1,10-phenantroline-5,6-dione (phendione) (A), [Cu(phendione)3](ClO4)2.4H2O (Cu-phendione) (B) and [Ag(phendione)2]ClO4
(Ag-phendione) (C). Perchlorate anions and water molecules have been omitted for clarity.
to approach large systems containing many atoms such as
proteins, DNA and other molecular systems comprising tens of
thousands of atoms (Morgon and Coutinho, 2007). Therefore,
the phendione-based compounds being considered in the present
study, having been docked in the lasB active site, were subjected
to PM6 calculations in order to obtain their interaction energy,
according to Equation (4):
Eint = Esystem/interm − Esystem − Einterm (4)
The application of these techniques is quite important in order to
acquire a better understanding of the possible interaction modes
of the test compounds within the lasB active cavity.
Microorganisms
In the present work, two P. aeruginosa strains were used in
the experiments: a reference strain (ATCC 27853), which was
formerly isolated from blood (Medeiros et al., 1971) and a
bloodstream clinical isolate named 09HC (Silva et al., 2014).
Both P. aeruginosa strains were previously characterized by
our research group regarding their antimicrobial susceptibility
profiles: 09HC strain was resistant to ceftazidime, meropenem
and imipenem, while the ATCC strain was susceptible to the three
antimicrobials (Silva et al., 2014).
Planktonic- and Biofilm-Growing
P. aeruginosa Cells
P. aeruginosa cells were grown on trypticase soy agar (TSA;
Merck, Darmstadt, Germany) for 18 h at 37◦C. Subsequently,
planktonic bacterial cells were subcultured in tryptone soy broth
(TSB) supplemented with 1% glycerol, 50 mM glutamate, 10 mM
CaCl2 and 10 mM ZnCl2 and incubated for 24 h at 37◦C
under constant agitation (Marquart et al., 2005). Cultures were
centrifuged (4000 rpm, 20 min, 4◦C) and bacterial cells were
washed three times in phosphate-buffered saline (PBS; 150 mM
NaCl, 20 mM phosphate buffer, pH 7.2). In parallel, the spent
culture supernatants were filtered through a 0.22 µm membrane
(Millipore, São Paulo, Brazil). The biofilm formation assay
was carried out as described previously by Silva et al. (2014).
Briefly, a bacterial suspension was prepared corresponding to
0.5 McFarland turbidity scale (∼108 colony-forming units/mL)
in TSB medium. Next, 100 µL of the culture was pipetted
into each well of a flat-bottomed 96-well polystyrene plate and
incubated for 24 h at 37◦C. Subsequently, biofilm supernatants
were collected, combined in a single tube and filtered through a
0.22 µm membrane.
Processing of the Supernatants for
Enzymatic Measurements
The cell-free supernatants were concentrated 10-fold in a
10,000 molecular weight cut-off Centricon micropartition system
(Amicon, Beverly, MA, United States). The protein concentration
was determined using the method described by Lowry et al.
(1951), using bovine serum albumin (BSA; Sigma-Aldrich,
United States) as standard.
LasB Activity Measurement
The activity of secreted lasB was measured using a microtiter-
based assay as described by Cathcart et al. (2011), and
which consisted of the proteolytic cleavage of a specific
fluorogenic peptide substrate, aminobenzyl-Ala-Gly-Leu-Ala-
p-nitrobenzylamide (Peptides International, Louisville, KY,
United States), bonded to the elastase of P. aeruginosa. The
reaction mixtures (100 µL) containing the purified lasB of
P. aeruginosa (Elastin Products Company, Owensville, MO,
United States) at 10 ng per 100 µL/well or cell-free supernatants
(20 µg of protein), the peptide substrate (200 µM) and
the reaction buffer (50 mM Tris–HCl, 2.5 mM CaCl2, pH
7.2) were incubated in the absence or in the presence of
different concentrations of phendione, Ag-phendione, Cu-
phendione and simple salts (AgNO3 and CuSO4.5H2O). The
fluorescence was monitored over 20 min at 30 s intervals
using a SpectraMax Gemini XPS Fluorescence Microplate
Reader (Molecular Devices, LLC, United States) at an excitation
wavelength of 330 ± 10 nm and an emission wavelength of
460± 10 nm. The inhibitory constant (Ki) values were calculated
using a derivation of the Michaelis–Menten equation employing
GraphPad Prism 6.1. The Michaelis–Menten constant (Km) value
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for the substrate, required for the calculation, was experimentally
determined as 13.2 µM using a Lineweaver–Burk Plot.
Zymography Assay
The protease profile was assayed by means of sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS–
PAGE) containing 0.1% gelatin incorporated into the gel as
proteinaceous substrate (Heussen and Dowdle, 1980). Gels were
loaded with 40 µg of proteins per slot. After electrophoresis
at a constant voltage (120 V) at 4◦C, SDS was removed by
incubation with 10 volumes of 2.5% Triton X-100 for 1 h at
room temperature under constant agitation. In order to promote
the proteolysis, the gels were incubated for 24 h at 37◦C in the
digestion buffer comprising 50 mM Tris–HCl, 10 mM CaCl2,
1 mM ZnCl2 and 150 mM NaCl, pH 8.0 (Marquart et al., 2005).
The gels were stained for 2 h with 0.2% Coomassie brilliant blue
R-250 in methanol:acetic acid:water (50:10:40) and destained
overnight in a solution containing methanol:acetic acid:water
(5:10:85), to intensify the digestion halos. The molecular masses
of the proteases were calculated by comparison with the mobility
of low molecular mass standards (Sigma-Aldrich). The gels were
dried, scanned and digitally processed.
Bacterial Treatment With
Phendione-Based Compounds
In order to investigate the impact on lasB production by treating
living P. aeruginosa cells with phendione-based compounds,
bacterial cells (106) were cultured in TSB medium for 24 h at
37◦C with shaking in the absence and in the presence of each
compound at the concentration corresponding to the 1/2 × MIC
value, as previously established by our group (Viganor et al.,
2016): phendione (3.125 µg/mL, 14.91 µM), Ag-phendione
(6.25 µg/mL, 9.93 µM) and Cu-phendione (6.25 µg/mL,
6.53 µM). After the treatment period, the bacterial cultures were
centrifuged in order to obtain the cell-free supernatants (which
were used to detect the lasB protein by Western blotting) and the
bacterial cells [which were used to analyze the expression of the
lasB gene by real time-polymerase chain reaction (RT-PCR)].
LasB Immunodetection
The detection of lasB extracellularly released into the culture
supernatant was performed using a Western blotting assay
(Marquart et al., 2005). Briefly, proteins (100 µg) present in
the cell-free supernatants were mixed with SDS-PAGE sample
buffer (125 mM Tris, pH 6.8, 4% SDS, 20% glycerol, 0.002%
bromophenol blue and 10% β-mercaptoethanol) followed by
heating at 100◦C for 5 min. Proteins were then separated on 12%
SDS–PAGE and the polypeptides electrophoretically transferred
at 4◦C at 100 V/200 mA for 2 h to a nitrocellulose membrane.
Non-specific protein biding sites were blocked using 5%
skimmed milk in TBS-Tween (150 mM NaCl, 10 mM Tris, 0.05%
Tween 20, pH 7.4) for 1 h at room temperature under constant
agitation. The membrane was washed three times in TBS-Tween
and then incubated with the anti-lasB primary polyclonal
antibody (kindly provided by Dr. Richard O’Callaghan,
University of Mississippi Medical Center, United States), which
was diluted at 1:500, for 4 h. The secondary antibody used was
peroxidase-conjugated goat anti-rabbit IgG at 1:10,000, followed
by chemiluminescence immunodetection using an ECL kit
(GE Healthcare, Chicago, IL, United States) (Marquart et al.,
2005). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
is a highly conserved protein that is constitutively secreted
into the extracellular environment via vesicles released from
the outer membrane of P. aeruginosa cells (Kim et al., 2013;
Vanden Bergh et al., 2013). Based on this information, the
polyclonal anti-human GAPDH antibody produced in rabbit
(Sigma-Aldrich), at 1:10000 dilution, was selected and used
as a loading control. Thus, in order to confirm the homology
between human and pseudomonal GAPDH, we aligned the
both protein sequences and then calculated the homology score
using clustal2.1 (Supplementary Figure S1). The homology
score is defined as the number of identities (same amino acid
residue in the best alignment divided by the number of residues
compared (gap positions are excluded). Thus, the comparison of
the sequence of P. aeruginosa GAPDH reveals 47.11% homology
with the human GAPDH. In addition, considering the conserved
substitutions and semi−conserved substitutions in pairwise
score calculations, the similarity score between human and
pseudomonal GAPDH increased to 78.50%. Taken together,
these data support the recognition of pseudomonal GAPDH
protein by the anti-GAPDH antibody used in our experiment.
The relative molecular masses of the reactive polypeptides were
calculated by comparison to the mobility of low molecular mass
protein standards (Sigma-Aldrich).
RT-PCR for Detection of LasB Gene
Total RNA isolation was performed using a TRIzol R© bacterial
RNA isolation kit (Thermo Fisher Scientific, Waltham,
MA, United States) in accordance with the manufacturer’s
instructions. The concentration of RNA was measured
using Nanodrop 2000 (Thermo Fisher Scientific) and the
quality was evaluated by resolving on a 1.5% agarose gel
at 120 V. Real-time one-step PCR was performed in a 96-
well plate on the purified RNA samples according to the
QuantiFast R© SYBR R© Green RT-PCR Handbook protocol
(Qiagen, Germany). Five microliters of both forward and
reverse primers (1 µM) and 1 µl RNA (∼100 ng) were added
to each well (final volume of 50 µL). The primers used were
lasB (forward: 5′-AAGTGCTCGATCAGTGGGAA-3′ and
reverse: 5′-CTGCTTGTAGGTGTTGGTCG-3′, designed using
Primer3 Output program) and the housekeeping gene rpoD
(forward: 5′-GGGCGAAGAAGGAAATGGTC-3′ and reverse:
5′-CAGGTGGCGTAGGTGGAGAA-3′) (Savli et al., 2003). As
previously reported (Savli et al., 2003; McMillan and Pereg, 2014),
the RpoD gene was selected because its expression is stable under
stress conditions. In the present study, no significant alterations
were reported in the rpoD gene expression in either untreated or
phendione-treated cells (Supplementary Figure S2). To do this,
samples were analyzed on a Light Cycler 480 (Roche Life Science,
Sussex, United Kingdom) employing the following program:
PCR initial activation step at 95◦C for 15 min, followed by 45
cycles of 95◦C for 10 s (denaturation), 63◦C for 10 s (annealing)
and 72◦C for 10 s (extension), then cooling at 4◦C. Finally, the
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11CT value was used to determine the fold change in expression
(Schmittgen and Livak, 2008).
Effects of Phendione-Based Compounds
on the LasB-Induced Damage to A549
Cells
A549 (human alveolar basal epithelial cell line, ATCC CCL-185)
cells were maintained in 75 cm2 cell culture flasks containing
Dulbecco’s modified Eagle medium (DMEM; Sigma-Aldrich)
supplemented with 10% heat-inactivated fetal bovine serum
(FBS) and 2 mM L-glutamine at 37◦C in an atmosphere of 5%
CO2. For the experiments, A549 cells were seeded (104 per well)
into 96- or 24-well plates containing the above medium and
grown to confluence. Firstly, 50 µL of the cell-free pseudomonal
supernatant (equivalent to 100 µg protein) and purified lasB
(10 ng protein) were previously treated with 25 µM of each
phendione-based compound for 1 h at 37◦C. Then, 20 µL each
of the neutralized supernatant and the neutralized purified lasB
were added to the A549 monolayer in 180 µL of fresh DMEM,
followed by incubation for 48 h at 37◦C in an atmosphere of
5% CO2. In parallel, A549 cells exposed only to phendione-
based compounds were used as a viability control. Cell viability
was determined by the reduction of the 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium (MTT) bromide salt, and
the integrity of the monolayer as well as the cell morphology were
observed using light-field microscopy (Aoki et al., 2010).
Effects of Phendione-Based Compounds
on the Purified LasB- and LasB-Rich
Bacterial Secretions-Induced Toxicity on
Galleria mellonella Larvae
Larvae of G. mellonella were obtained at the insectarium
of Biochemistry Department, Chemistry Institute from UFRJ,
Brazil. Breeding and maintenance of G. mellonella larvae
were carried out as previously described (Fernandes et al.,
2017). Larvae from the last instar employed in experiments
were selected after reaching similar size (15–20 mm), weight
(approximately 200 mg) and by the absence of gray pigmentation
(Fernandes et al., 2017). Prior to the infection assay, the
supernatants of P. aeruginosa strains (ATCC 27853 and 09HC)
were obtained, filtered and concentrated as described above.
Then, groups of 10 larvae were inoculated with 10 µL of the
(i) pseudomonal supernatants (containing 100 µg of protein),
(ii) thermal-inactivated supernatants (100◦C for 5 min) and
(iii) purified LasB molecules (1 µg) by directly injection into
the hemocoel via the last left pro-leg, using a 25 µL Hamilton
syringe. As a physical injury control, the same volume of PBS
was also inoculated into G. mellonella larvae. In addition, an
extra control group of larvae without any inoculation were
employed to evaluate the health of larvae during the follow-up
of the experimental conditions. After injection, the larvae were
incubated in glass dishes without food and in the dark at 37◦C
for up to 7 days. Survival was appraised daily at the same time as
the beginning of the experiment, and the larvae were considered
as being dead when no reaction was observed upon stimulus
(Fernandes et al., 2017; Rizzo et al., 2017). Survival was expressed
as the percentage of living larvae along the experimental time
(Fernandes et al., 2017; Rizzo et al., 2017). In parallel, we
investigated the ability of Cu-phendione to prevent larvae death
induced by purified LasB and by LasB-rich bacterial secretions.
To do this, different concentrations (1, 10, and 100µg of protein)
of the bacterial supernatant obtained from ATCC 27853 strain
and the purified LasB (1 µg) were previously treated with 50 µM
Cu-phendione solution for 30 min at room temperature and,
subsequently, 10 µL were inoculated into the larvae and survival
rates were monitored daily for 7 days.
Statistics
Experiments were performed in triplicate, in three independent
experimental sets, and data were expressed as mean ± standard
deviation. The results were evaluated by analysis of variance
(ANOVA) and Dunnett’s multiple comparison test using
GraphPad Prism 6 computer software. In in vivo experiments,
statistical significance was plotted using Kaplan–Meier curves on
GraphPad Prism 7.0 software. In all analyses, P-values of 0.05 or
less were considered statistically significant.
RESULTS
Docking of the Phendione-Based
Compounds With the
LasB-Encapsulated HPI/LasB Active
Site: In silico Approaches
The possible interactions between the phendione-based
compounds and the lasB-encapsulated HPI/lasB active site were
investigated using molecular docking methods (Figure 2 and
Table 1). The docking of the phendione-based test compounds
to the lasB active inhibitor ligand, HPI, revealed that Cu-
phendione adhered firmly to HPI via pi-stacking interactions
between aromatic rings (Figures 2E,F). Furthermore, the
docking calculations showed that Cu-phendione had the greatest
interaction energy (−127.54 kcal mol−1), followed by phendione
(−40.47 kcal mol−1) and Ag-phendione (−34.26 kcal mol−1)
(Table 1). Corroborating these findings, it was also observed
that Cu-phendione was able to form two hydrogen bonds with
amino acid residues (Arg198 and Asn112) in the lasB catalytic
site, as well as two other hydrogen bonds with water molecules
(Figures 2E,F and Table 1). Likewise, Ag-phendione established
interactions with the lasB catalytic site by forming one hydrogen
bond with one amino acid residue (Ala113) and three water
molecules (Figures 2C,D and Table 1), while phendione
interacted only moderately with the lasB active site forming
just two hydrogen bonds (with Arg198 and one water molecule;
Figures 2A,B and Table 1).
In addition, semi-empirical calculations were performed at
PM6 level in order to obtain more precise values of their
hydrogen bonding interaction energies with amino acid residues
within the cavity of the lasB enzyme, and comparing these
new findings with those obtained by the docking analyses. In
agreement with the docking data, Cu-phendione presented the
greatest relative interaction energy (0 kcal mol−1), followed by
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TABLE 1 | Results of the in silico analyses showing the interaction energies of the phendione-based compounds with the lasB-encapsulated HPI/lasB active site.
Molegro Virtual Docker Semi-empiric – PM6
Compounds Interaction energy (kcal mol−1) Hydrogen bonds Interaction energy (kcal mol−1)
Phendione −40.47 1 Arg198 1 H2O 4.179
Ag-phendione −34.26 1 Ala113 3 H2O 2.690
Cu-phendione −127.54 1 Arg198 1 Asn112 2 H2O 0.000
FIGURE 2 | Molecular docking diagrams showing the bonding interactions between the phendione compounds and the lasB-encapsulated HPI/lasB active site of
P. aeruginosa. Docking of phendione (A), Ag-phendione (C) and Cu-phendione (E) with the N-(1-carboxy-3-phenylpropyl)phenylalanyl-α-asparagine moiety
illustrated using ball and stick models, and pi-stacking interactions are highlighted in red dashed lines. Hydrogen bonds between lasB, water molecules and
phendione (B), Ag-phendione (D) and Cu-phendione (F) are shown with blue dashed lines.
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Ag-phendione (2.690 kcal mol−1) and phendione (4.179 kcal
mol−1) (Table 1). The interaction energies of phendione and
Ag-phendione were quite similar (energy difference 1.489 kcal
mol−1) and a parallel trend was also observed from the
docking studies. Based on these findings, it is evident that
phendione and its metal-based complexes could actively interact
with lasB. Given that Cu-phendione presented the best fit
to the HPI/lasB active site model and also had the greatest
interaction energy, this metal complex presents the most
favorable attributes for interaction with the P. aeruginosa lasB
catalytic site.
Effects of Phendione-Based Compounds
on the LasB Enzymatic Activity
Following the in silico analyses, the in vitro impact of
the phendione compounds on the enzymatic activity
of lasB was investigated using a specific fluorogenic
peptide substrate (Cathcart et al., 2011). In support
of the above in silico results, Cu-phendione had the
greatest inhibitory action on the purified lasB [having
the lowest inhibitory constant value (Ki = 0.09 µM)],
followed by Ag-phendione (Ki = 0.31 µM) and phendione
(Ki = 0.38 µM) (Figure 3). The simple salts, CuSO4.5H2O
and AgNO3, did not significantly alter the elastinolytic
activity (Figure 3).
It is well known that lasB is physiologically released into
the extracellular environment by P. aeruginosa cells (Galdino
et al., 2017; Azam and Khan, 2018). As expected, phendione, Ag-
phendione and Cu-phendione were able to block the proteolytic
activity of lasB present in the supernatants harvested from
planktonic-growing P. aeruginosa cells (ATCC 27853 and 09HC)
(Figure 3). Cu-phendione at a concentration of 10 mM, inhibited,
respectively, 95.18 and 93.44% of the lasB activity detected
in the secretions of planktonic-growing bacterial cells of both
ATCC 27853 and 09HC strains (Figures 3B,C). Furthermore,
Cu-phendione robustly inhibited (∼90%) of the lasB activity
in supernatants recovered from ATCC 27853 biofilm-growing
cells (Figure 3D).
Effect of Phendione-Based Compounds
on LasB Gene Expression and LasB
Protein Secretion
In this set of experiments, we evaluated whether phendione-
based compounds would be able to control lasB gene expression,
as well as the production of its mature protein product,
the lasB secreted form. To do this task, live P. aeruginosa
cells were subjected to sub-inhibitory concentrations (values
corresponding to 1/2 × MIC) of the test compounds for a
24 h period. Phendione and its metal-containing complexes
down-regulated the lasB gene expression in a similar way,
reducing it by approximately 50% compared with the untreated
cells (Figure 4A). In addition, the amount of lasB protein
present in the planktonic supernatant was significantly reduced
following treatment with sub-inhibitory concentrations of
phendione (14.70%), Ag-phendione (41.14%) and Cu-
phendione (71.43%), compared with the untreated bacterial
cells (Figure 4B).
Effect of Phendione-Based Compounds
on LasB-Induced Cell Damage
During tissue invasion by P. aeruginosa cells, the bacterial
lasB enzyme dislocates mammalian cellular layers by degrading
extracellular components (e.g., collagen types III and IV,
laminin, fibronectin and vitronectin) (Beaufort et al., 2013;
Reboud et al., 2016) and disrupts several tight junctions (e.g.,
occludin, claudin-1 and -4, and tricellulin) (Beaufort et al.,
2013; Nomura et al., 2014). Thus, it would be expected that
the inhibition of bacterial lasB activity by phendione-based
compounds would result in the attenuation of lasB-related
mammalian cell damage. With this proposition in mind, it
was observed that the incubation of a A549 monolayer with
either culture supernatants (100 µg of protein) or purified
lasB (10 µg) for 48 h reduced cell viability (Figures 5A,B)
and induced cell rounding and detachment (Figure 5C).
In addition, in the presence of either conditioned culture
supernatant or purified lasB from P. aeruginosa, the A549
viability decreased 37.03 and 14.38%, respectively, in comparison
with non-treated epithelial cells (Figures 5A,B). In contrast,
addition of the phendione-based compounds (at 25 µM)
protected epithelial cells from lasB-related cytotoxic effects,
based on the maintenance of A549 morphology and monolayer
confluence (Figure 5C). Furthermore, A549 viability was partially
restored in the presence of planktonic bacterial supernatant
previously incubated with phendione, Ag-phendione and Cu-
phendione (Figure 5B). Likewise, the treatment of purified lasB
molecules with phendione, Ag-phendione and Cu-phendione
reduced its ability to affect the growth of A549 cells by
approximately 28, 39, and 80%, respectively, compared to
A549 cells treated with lasB (Figure 5A). Finally, under
the experimental conditions employed herein, phendione, Ag-
phendione and Cu-phendione alone were not toxic to A549
cells when administered up to a concentration of 25 µM
(data not shown).
Effects of Phendione-Based Compounds
on the Purified LasB- and LasB-Rich
Bacterial Secretions-Induced Toxicity on
G. mellonella Larvae
Given the inhibitory activity of phendione-based compounds on
in vitro lasB enzymatic activity, the efficacy of Cu-phendione
(the most potent lasB inhibitor) on the attenuation of the
toxicity of pseudomonal supernatant was explored in an in vivo
infection model using the larvae of the insect, G. mellonella.
Firstly, the protective ability of Cu-phendione was tested
against the in vivo toxicity mediated by the supernatants
obtained from the ATCC 27853 and 09HC strains (Figure 6A).
The pseudomonal secretions from the resistant strain (09HC)
exhibited an attenuated virulence profile on G. mellonella
larvae compared with the reference strain ATCC 27853. In a
comparative perspective, 100 and 70% of the larvae inoculated
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FIGURE 3 | Effects of the phendione-based compounds on the elastinolytic activity of P. aeruginosa. The enzymatic activity was measured using a specific
fluorogenic peptide substrate to P. aeruginosa elastase, taking into consideration the following experimental systems: purified pseudomonal lasB molecules (A),
supernatants obtained from planktonic growth of two P. aeruginosa strains, ATCC 27853 (B) and 09HC (C), and supernatant-derived from the biofilm of the ATCC
27853 strain (D). Before the enzymatic quantification, each system was treated for 30 min with different concentrations (0, 0.001, 0.01, 0.1, 0.5, 1, and 2 mM for the
purified lasB, and 1, 2.5, 5, and 10 mM for the conditioned bacterial supernatants) of the phendione-based compounds or simple Ag+ and Cu2+ salts.
with ATCC- and 09HC-obtained supernatants, respectively,
died after the first 24 h of inoculation (Figure 6A). Further,
the heated-supernatant from the ATCC strain (a classical
enzymatic inactivation process) was considerably less toxic to
the larvae compared with the fresh, non-heated counterpart
(Figure 6A). Interestingly, lasB production was significantly
different for the two bacterial strains (as judged either by the
cleavage of a P. aeruginosa elastase-specific peptide substrate
or by gelatin-containing zymography assays), with the ATCC
strain producing around 1.4-times more lasB than the 09HC
strain (Figure 6B).
Since the ATCC 27853-derived supernatant was more toxic
toward G. mellonella, this sample was selected in order to
assess the possible beneficial effects of Cu-phendione in the
in vivo scenario. Different supernatant concentrations were
previously incubated in the absence or presence of Cu-phendione
(50 µM) for 30 min and then injected into the larvae. It
was found that the P. aeruginosa supernatant was noxious
to G. mellonella larvae in a typical dose-dependent manner
(Figure 6C). Interestingly, Cu-phendione mitigated the toxic
effect of lasB-containing bacterial secretions, increasing the
survival rate of the G. mellonella larvae (Figure 6C). In
addition, purified lasB protein was also able to induce larval
death and Cu-phendione exerted a protective effect against
this toxic action (Figure 6D). Cu-phendione alone was not
toxic to G. mellonella larvae in concentrations up to 50 µM
(data not shown).
DISCUSSION
Considering the worldwide crisis of bacterial resistance,
P. aeruginosa is a constant threat in relation to community- and
hospital-acquired infections, primarily because of the emergence
and quick spread of refractory strains that are unresponsive
to every clinically available antimicrobial drug (Strateva and
Yordanov, 2009). So, the arising and foreseeable failure of
classical antimicrobial therapies have spurred the scientific
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FIGURE 4 | Effects of phendione-based compounds on P. aeruginosa lasB gene expression and lasB protein production. Bacterial cells were treated with 0.5 × MIC
of phendione (16.15 µM), Ag-phendione (7.02 µM), and Cu-phendione (3.88 µM) for 24 h at 37◦C. Evaluation of lasB gene expression by RT-PCR (rpoD gene was
used as a housekeeping gene) (A). Detection of production/secretion of lasB protein by western blot using an anti-lasB antibody (GAPDH was used as loading
control) (B). In (B), the numbers on the right indicate the molecular masses of the reactive proteins. Reactive bands were densitometrically quantified using the
ImageJ software and the results were expressed as a correlation between lasB and GAPDH densitometric values (expressed as arbitrary units). The symbols
(∗P < 0.05, one-way ANOVA, Dunnett’s multiple comparison test) denote the statistically difference among phendione-treated systems and untreated ones.
community to develop new strategies to tackle MDR pathogens
(Dickey et al., 2017).
Pseudomonas aeruginosa possesses a devastating suite of
virulence attributes, which act together to enhance the ability of
the pathogen to cause host cell damage and, consequently,
to aggravate the infectious process and disease course
(Balasubramanian et al., 2013). For this reason, the purpose
of targeting the bacterial virulence arsenal is a veritable and
promising approach to the development of alternative drugs,
which act by attenuating the aggressiveness of the pathogen
and by reducing its ability to cause a vigorous infection (Dickey
et al., 2017). Since this anti-virulence approach does not target
main, vital bacterial pathways, these new therapeutics impose
less selective pressure than the classical antimicrobial drugs,
so preventing or delaying the emergence of the drug-resistant
phenotype (Dickey et al., 2017). Moreover, the majority of
virulence factors are specific to either a single or a few closely
similar species. Thereby, the horizontal gene transfer of resistance
genetic elements of an anti-virulence drug would be reduced
(Totsika, 2016).
In recent times, our group has been exploring the
antimicrobial potential of 1,10-phenanthroline- and phendione-
based compounds (McCann et al., 2012a; Viganor et al., 2017).
In this sense, we previously reported that the coordination
of the phendione ligand to transition metals represents a
new and promising group of antibiotic drugs, in which both
Ag-phendione and Cu-phendione have exhibited a striking
anti-P. aeruginosa effect against both planktonic- and biofilm-
forming cells (Viganor et al., 2016). Moreover, these compounds
were able to kill metronidazole-resistant Trichomonas vaginalis
clinical isolates (Rigo et al., 2018) and they were active against
several fungi such as Phialophora verrucosa, Scedosporium
apiospermum, Candida albicans, and Candida haemulonii
(McCann et al., 2012a; Gandra et al., 2017; Granato et al., 2017).
Herein, we investigated the applicability of phendione-based
compounds as anti-virulence drugs through the blockage of
pseudomonal lasB activity.
LasB belongs to the metalloprotease class of enzymes (Zn2+
and Ca2+ cofactors), and thus the addition of metal-chelator
molecules (ligands) with the capability of abstracting the central
metal ion from the protein are expected to inhibit its enzymatic
activity. Accordingly, multidentate EDTA and EGTA prevent
lasB enzymatic activity by sequestering both Zn2+ and Ca2+
ions that are essential for its proteolytic activity and its three-
dimensional structure, respectively (Kocabiyik et al., 1995; Aoki
et al., 2010). In contrast, phendione-based compounds may
inhibit the elastinolytic activity of lasB by blocking the access of
the host substrate to the active site. LasB has the ability to cleave
a broad variety of proteinaceous substrates, hydrolyzing internal
peptide bonds of proteins specifically on the amino portion
of hydrophobic amino acid residues (Miyoshi and Shinoda,
2000). Furthermore, the S1’ sub-site within the active site is a
deep hydrophobic pocket that accepts bulky aromatic and large
aliphatic chain groups (Carson et al., 2012). For this reason, it is
possible that the hydrophobic skeleton of the phendione-based
compounds could interact with that section of the lasB active site.
Using in silico approaches, it was observed that phendione
and its metal complexes overlapped with the lasB active and
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FIGURE 5 | Effects of phendione-based compounds on P. aeruginosa lasB-induced cellular damage to lung epithelial cells (A549 line). Purified lasB (A) and
pseudomonal conditioned supernatant (B) were previously incubated with phendione-based compounds at 25 µM for 1 h. Then, the lung epithelial cells were
incubated for 48 h in the presence of P. aeruginosa supernatant (100 µg protein) or purified lasB (10 ng protein). After 48 h of incubation, A549 viability was analyzed
using the MTT assay (A,B). In parallel, the integrity of the A549 monolayer and cell morphology were observed by light microscopy (C). The asterisks (∗) denote
significant difference between non-treated and treated cells (P < 0.05, ANOVA – Dunnett’s multiple comparison test), setting the untreated cells as a comparative
parameter. < 0.05 – One-way ANOVA (Dunnett’s multiple comparison test), setting the supernatant-treated cells as a comparative parameter.
standard ligand, HPI. Cu-phendione, in particular, encompassed
compatible structural moieties of the HPI, principally pi-stacking
interactions between the aromatic rings. HPI binds to the
active site in the S1-S1’ sub-sites of lasB by hydrogen bonding,
hydrophobic and weak van der Waal’s interactions (Lutfullah
et al., 2008). Given the apparent compatibility of the phendione-
based compounds with HPI, it is conceivable that they may
interact with the lasB active site in a similar fashion, with
the trend: Cu-phendione > Ag-phendione > phendione. Zhu
et al. (2015) described mercaptoacetamide-derivative compounds
as an effective class of lasB inhibitors, and the docking
analysis showed that the amide portion of mercaptoacetamide
compounds interact with Asn112 residue and the phenyl ring
shielding some of the hydrophobic residues consisting of Phe129,
Leu132, Val137, Ile190, and Leu197, blocking the enzymatic activity
of lasB. Likewise, the current in silico study suggested that Cu-
phendione was able to interact with the P. aeruginosa lasB
sub-site S1 by binding to Arg198 and Asn112.
After evaluating the potential molecular interactions between
pseudomonal lasB and the phendione compounds, the enzyme
inhibition effectiveness was confirmed by in vitro measurements.
It was observed that phendione and its Ag+ and Cu2+
coordination complexes were able to completely inhibit the
proteolytic activity of purified lasB from P. aeruginosa in a typical
dose-dependent fashion. Moreover, the test compounds inhibited
the lasB elastinolytic activity in the supernatants obtained from
bacterial cells grown under both planktonic and biofilm lifestyles.
As predicted by the molecular docking studies, Cu-phendione
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FIGURE 6 | In vivo effects of phendione-based compounds on the lasB-induced toxicity against G. mellonella larvae. Firstly, the toxic effects of cell-free culture
supernatants obtained from ATCC 27853 and 09HC were evaluated. In this way, fresh and thermally inactivated (100◦C/5 min) bacterial supernatants (100 µg) were
injected into the larvae hemocoel (10 per group), and the larvae survivability was followed up for 7 consecutively days (A). The presence of lasB in the pseudomonal
supernatants was confirmed by the cleavage of the specific fluorogenic peptide substrate (aminobenzyl-Ala-Gly-Leu-Ala-p-nitrobenzylamide) and by
gelatin-zymography. The molecular mass on the right evidences the elastase proteolytic band. Note the significant difference regarding the elastase production by
both P. aeruginosa strains (B). Subsequently, Cu-phendione was tested on its ability to revert the toxic effects of both bacterial supernatants (C) and purified lasB
molecules (D). In this set of experiments, different concentrations (1, 10, and 100 µg of proteins) of P. aeruginosa ATCC 27853 secretions and purified lasB
molecules (1 µg) were treated or not with 50 µM Cu-phendione for 30 min at room temperature. Then, both untreated and Cu-phendione-neutralized systems were
injected into larvae hemocoel (10 per group), and the larvae survival was checked daily for 7 days. The survival data were plotted using the Kaplan–Meier method
using GraphPad Prism v 7.0.
was the compound best able to block the P. aeruginosa lasB
enzymatic activity.
Given the potential of lasB as a target for the development
of a new anti-virulence drug, several other research groups
have described the inhibitory action of natural and/or synthetic
molecules on the lasB activity of P. aeruginosa. It was reported
that sub-inhibitory concentrations of some FDA-approved
antibiotics modulated the P. aeruginosa virulence attributes.
For instance, erythromycin, at a concentration of 8 µg/mL,
abolished the elastinolytic activity of 20 out of 34 (58.5%)
P. aeruginosa clinical strains recovered from the sputum of
patients suffering from various airway infections (Sakata et al.,
1993). It was also observed that treatment with a sub-inhibitory
concentration of doxycycline (4 µg/mL) decreased the secretion
of lasB by 67% (Husain and Ahmad, 2013). Moreover, the
administration of a sub-inhibitory concentration of tobramycin
(0.063 mg/L) combined with bismuth-ethanedithiol (0.1 µM)
decreased lasB production by 70% in the P. aeruginosa PAO1
reference strain (Alipour et al., 2010). It was reported that
analogs of 3-hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones
effectively blocked the lasB activity of the P. aeruginosa
PA14 strain, exhibiting IC50 values of approximately 3 µM
(Garner et al., 2012). Also, the synthetic N-α-mercaptoacetyl
dipeptides, HS-CH2-CO-Phe-Tyr-NH2 and HS-CH2-CO-Trp-
Tyr-NH2, showed high activity against lasB, presenting Ki values
of 41 and 40.5 nM, respectively (Cathcart et al., 2011). The
valuable application of metal nanoparticles to anti-virulence
therapy has also been highlighted, again due to their anti-
lasB attributes. Nanoparticulate zinc oxide (at 200 µg/mL)
completely blocked pseudomonal elastinolytic activity, besides
offering protection against elastase-induced tissue destruction
and epithelial ulceration in rabbit skin burns (Ali et al.,
2017). Likewise, an association of selenium nanoparticles with
polyphenols obtained from honey (at 4.5 µg/mL) inhibited
52.7% of the pseudomonal lasB activity of the PAO1 reference
strain (Prateeksha et al., 2017). Furthermore, metabolites derived
from the fungus Rhizopus arrhizus, when associated with silver
nanoparticles (at 25 µg/mL), repressed lasB gene expression
in P. aeruginosa by 84% (Singh et al., 2015). Our current
investigation revealed that Ag-phendione and Cu-phendione
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were powerful lasB inhibitors, presenting inhibition constant (Ki)
values of 0.31 and 0.09 µM, respectively. Additionally, treating
P. aeruginosa cells with sub-inhibitory concentrations of the
phendione-based compounds repressed the expression of the
lasB gene as well as preventing the production and/or secretion
of mature lasB protein. The molecular mechanisms underlying
reduced lasB gene expression and other virulence factors in
P. aeruginosa is due to the QS regulatory networks. It is well
known that QS regulatory networks respond to environmental
stress cues (including inhibitors and other chemical compounds),
and the two main regulatory networks are las and rhl gene
systems that activate the expression of QS-responsive genes (and
proposed to constitute nearly 10% of the P. aeruginosa genome).
However, more recent studies have reported the existence of
two additional QS networks (quinolone-based and integrated
QS) that are integrated and interconnected with the las and
rhl systems (Lee and Zhang, 2015). Therefore, we suggest
that the decrease in lasB expression observed in the current
investigation is most likely as a consequence of the phendione-
based compounds exerting their effects on the QS networks. This
line of investigation is complex and time-consuming, but it is in
progress by our research group.
The invasiveness of P. aeruginosa throughout host tissues
is mediated by the action of lasB (Reboud et al., 2016). LasB
promotes the degradation of extracellular matrix proteins, aside
from cleaving some essential cell-to-cell and cell-to-matrix
adhesion receptors important for the maintenance of the integrity
of the endothelial barrier (Beaufort et al., 2013). Consequently,
at least in theory, the inhibition of lasB activity could negate
its cytotoxic effects and therefore attenuate the pathogenesis
of a P. aeruginosa infection. In this context, the protective
effectiveness of several anti-lasB molecules has been reported.
The co-incubation of P. aeruginosa culture supernatant with
Ca-EDTA curtailed the destructive effect of lasB on the A549
line, restoring 26.5% of mammalian cell viability upon addition
of a solution of Ca-EDTA (8 µg/mL) (Aoki et al., 2010). It
was also demonstrated that phosphoramidon, a classical lasB
inhibitor, delayed elastase-related cornea damage for a period
of 12 h (Kawaharajo et al., 1982). Diethylene triamine penta-
acetic acid (DTPA) has also been proposed as a lasB inhibitor,
since a 20 µM solution significantly decreased lasB production
in the P. aeruginosa PAO1 strain (Gi et al., 2014). Moreover, the
treatment of PAO1 cells with 50 µM DTPA reduced the amount
of lasB in the pseudomonal supernatant. Thus, DTPA-treated
cells produced a supernatant that was non-toxic toward lung cells
(Gi et al., 2014). The present experiments have demonstrated that
phendione and its metal-based compounds, at a concentration of
25 µM, also have the ability to block the cytotoxic effect of lasB
on lung epithelial cells.
The usefulness of invertebrate model hosts has become
popular amongst the research community due to their
numerous advantages over mammalian models, which includes
ethical, logistical and budgetary features (Pereira et al., 2018).
Moreover, since invertebrates are multicellular organisms
with differentiated tissues and distinct organs, this sort of
in vivo model could provide more robust results that may help
more in the understanding of the biological effects of drug
treatment (Pereira et al., 2018). In this scenario, G. mellonella
is a convenient tool for investigating microbial pathogenesis
and host responses, as well as helping in the understanding of
the antimicrobial activity of novel drug candidates (Kavanagh
and Sheehan, 2018). In the present study, the lasB-related
deleterious effect on G. mellonella larvae was measured, as well
as the ability of Cu-phendione to neutralize the toxic effect
induced by pseudomonal secretions that are rich in LasB. The
results suggested that ATCC 27853 and 09HC strains employed
different virulence strategies when infecting G. mellonella as
well as producing different degrees of LasB activity. Along the
same line, Andrejko et al. (2013, 2014) compared the virulence
profiles of the reference strain ATCC 27853 and two clinical
isolates of P. aeruginosa on G. mellonella (Andrejko et al.,
2013, 2014). Those authors reported that even though all of
the P. aeruginosa strains were able to produce and secrete
proteases, the elastase production were more relevant to the
ATCC 27853-infected larvae (Andrejko et al., 2013, 2014).
Inoculation of ATCC 27853 supernatant promptly activated
the phenoloxidase system in the G. mellonella larvae, which
plays a crucial role in the immunological response of the insect
(Andrejko et al., 2013). Moreover, the ATCC 27853 supernatant
promoted a stronger degradation of hemolymph polypeptides in
comparison to the other clinical isolates (Andrejko et al., 2014).
In another interesting study by Hwang and Yoon (2019), it
was demonstrated that antibiotic-resistant P. aeruginosa strains
were significantly less virulent in BALB/c mice than antibiotic-
susceptible strains (considering both the reference PAO1
strain and recent clinical isolates). Those authors correlated
a lower virulence profile of antibiotic-resistant P. aeruginosa
strains with their notably poor lasB production. Since the
ATCC 27853 supernatant was more toxigenic to G. mellonella
larvae, we selected this strain to further investigate the in vivo
anti-virulence effects of Cu-phendione. It was observed that
larvae inoculated with pseudomonal supernatant exhibited
lower survival rates when compared to the larvae that were
injected with a Cu-phendione-neutralized supernatant. Aoki
et al. (2010) showed that pseudomonal supernatant injected
into the lungs of mice induced death after 5 days. Contrarily,
mice infected with a Ca-EDTA-neutralized supernatant showed
a significant increase in survival rate in comparison to mammals
which were given the untreated-supernatant (Aoki et al.,
2010). Furthermore, considering the devastating role of lasB in
P. aeruginosa pathogenesis, the inhibition of this enzyme could
possibly suppress the successful establishment of the bacterial
infection. Previous studies have revealed that the deletion of
lasB gene culminates in a less invasive infection in rabbit corneal
epithelial cells (Cowell et al., 2003). Likewise, in vitro assays
demonstrated that mice and C. elegans infected by the 1lasB
strain of P. aeruginosa had less severe infections when compared
to the wide-type strain (Tan et al., 1999).
CONCLUSION
In conclusion, the strategic synthesis of new drug molecules
that target the inhibition of lasB is a desirable goal. In
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this light, we have now identified Ag-phendione and Cu-
phendione as powerful lasB inhibitors. Both of these metal
complexes were able to (i) interact with the active site of lasB, (ii)
decrease the activity of purified lasB and secreted lasB obtained
from bacterial supernatants, (iii) inhibit the lasB gene expression
and (iv) block the production of secreted lasB. Additionally,
due to their ability to inhibit lasB, these compounds nullified
the lasB cytotoxic effects on lung epithelial cells. Interestingly,
earlier in vivo experiments demonstrated that Ag-phendione
and Cu-phendione are well tolerated by G. mellonella larvae
and Swiss mice (McCann et al., 2012b). Importantly, we also
found that phendione-based compounds did not induce chronic
toxicity, maintaining the activity of aspartate aminotransferase
and alanine aminotransferase in treated mice at the same level
as that found in the untreated animal (McCann et al., 2012b).
Corroborating these previously findings, the current study has
shown that a Cu-phendione-neutralized supernatant promotes
a significant increase in the survival rate of G. mellonella larvae
challenged with P. aeruginosa secretions. Considering the in vitro
and in vivo LasB-inhibitory activity of Cu-phendione, coupled
with its low toxicity profile in both in vitro and in vivo models,
strongly suggests that this Cu2+ compound is a promising anti-
virulence therapeutic for the treatment of antibiotic-resistant
P. aeruginosa infections.
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FIGURE S1 | Schematic representation of protein sequences of both human and
pseudomonal glyceraldehyde 3-phosphate dehydrogenase (GAPDH). In order to
confirm the homology between human and pseudomonal GAPDH, we aligned the
both protein sequences and then calculated the homology score using clustal2.1.
The homology score is defined as the number of identities (same amino acid
residue in the best alignment divided by the number of residues compared (gap
positions are excluded). Thus, the comparison of the sequence of P. aeruginosa
GAPDH indicates only moderate homology with human GAPDH (47.11%).
However, considering conserved substitutions and semi-conserved substitutions
in pairwise score calculations, the similarity score between human and
pseudomonal GAPDH increased to 78.50%. Thus, the anti-human GAPDH
antibody was able to proper detect the pseudomonal GAPDH.
FIGURE S2 | Evaluation of P. aeruginosa rpoD gene expression by RT-PCR. The
expression level of rpoD gene was used as normalization factor of raw values of
lasB gene expression. For that, bacterial cells were treated with 0.5 × MIC of
phendione (16.15 µM), Ag-phendione (7.02 µM) and Cu-phendione (3.88 µM) for
24 h at 37◦C. Subsequently, the RNA was extracted and the levels of rpoD was
measured. It was observed that the treatment with phendione-derivate
compounds did not altered the rpoD gene expression.
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